These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 15969882

  • 1. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
    Munzel U, Marschall K, Fyrnys B, Wedel M.
    Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
    [Abstract] [Full Text] [Related]

  • 2. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 3. Scintigraphic comparison of budesonide deposition from two dry powder inhalers.
    Newman SP, Pitcairn GR, Hirst PH, Bacon RE, O'Keefe E, Reiners M, Hermann R.
    Eur Respir J; 2000 Jul 09; 16(1):178-83. PubMed ID: 10933104
    [Abstract] [Full Text] [Related]

  • 4. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method.
    Lähelmä S, Kirjavainen M, Kela M, Herttuainen J, Vahteristo M, Silvasti M, Ranki-Pesonen M.
    Br J Clin Pharmacol; 2005 Feb 09; 59(2):167-73. PubMed ID: 15676038
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation.
    Sebti T, Pilcer G, Van Gansbeke B, Goldman S, Michils A, Vanderbist F, Amighi K.
    Eur J Pharm Biopharm; 2006 Aug 09; 64(1):26-32. PubMed ID: 16697169
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro performance evaluation of the Novopulmon 200 Novolizer and Budesonid-ratiopharm Jethaler: two novel budesonide dry powder inhalers.
    de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW.
    Pharmazie; 2004 Sep 09; 59(9):692-9. PubMed ID: 15497751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
    Fyrnys B, Stang N, Wolf-Heuss E.
    Curr Opin Pulm Med; 2001 Apr 09; 7 Suppl 1():S7-11. PubMed ID: 11385814
    [Abstract] [Full Text] [Related]

  • 11. Systemic availability and lung deposition of budesonide via three different nebulizers in adults.
    Dahlström K, Thorsson L, Larsson P, Nikander K.
    Ann Allergy Asthma Immunol; 2003 Feb 09; 90(2):226-32. PubMed ID: 12602671
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Scintigraphic evaluation of lung deposition with a novel inhaler device.
    Newman SP, Hirst PH, Pitcairn GR.
    Curr Opin Pulm Med; 2001 Apr 09; 7 Suppl 1():S12-4. PubMed ID: 11385810
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
    Thorsson L, Geller D.
    Respir Med; 2005 Jul 09; 99(7):836-49. PubMed ID: 15939245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.